The Trouble with Troponin

Heart Lung and Circulation

Volumn 16, Issue SUPPL. 3, 2007, Pages

  McNeil, Alan ^a  

^a Dorevitch Pathology   (Australia)

Author keywords

Creatine kinase; Reference limits; Standardization; Troponin

Indexed keywords

FIBRIN; PROTEIN ANTIBODY; TROPONIN; TROPONIN ANTIBODY; TROPONIN I; UNCLASSIFIED DRUG;

ARTICLE; CONSENSUS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEART MUSCLE INJURY; HUMAN; IMMUNOASSAY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; STANDARDIZATION; THORAX PAIN;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CHEST PAIN; CREATINE KINASE; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TROPONIN;

EID: 34547745845     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.03.017     Document Type: Article

References (17)

1. Lin J.C., Apple F.S., Murakami M.M., and Luepker R.V. Rates of positive cardiac Troponin I and creatine kinase MB mass among patients hospitalised for suspected acute coronary syndromes. Clin Chem 50 (2004) 333-338
2. Bhagat C.I., Langton P., Lewer M., Ching S., and Beilby J.P. Cardiac Troponin I should replace CK MB for the diagnosis of acute myocardial infarction. Clin Biochem 34 (1997) 511-516
3. Stubbs P., Collinson P., Moseley D., Greenwood T., and Noble M. Prognostic significance of admission Troponin T concentrations in patients with myocardial infarction. Circulation 94 (1996) 1291-1297
4. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell F.E., Califf R.M., and Topol E.J. Cardiac Troponin T levels for risk stratification in acute myocardial ischaemia. N Engl J Med 335 (1996) 1333-1341
5. Christenson R.H., Duh S.-H., Newby L.K., Ohman E.M., Califf R.M., Granger C.B., Peck S., Pieper K.S., Armstrong P.W., Katus H.A., and Topol E.J. Cardiac Troponin T and cardiac Troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. Clin Chem 44 (1998) 494-501
6. McNeil A.R., Marshall M., Ellis C.J., and Hawkins R.C. Why is Troponin T increased in the serum of patients with end-stage renal disease?. Clin Chem 44 (1998) 2377-2378
7. Eriksson S., Hellman J., and Pettersson K. Autoantibodies against cardiac Troponins. N Engl J Med 352 (2005) 98-100
8. Christenson R.H., Duh S.H., Apple F.S., Bodor G.S., Bunk D.M., Dalluge J., Panteghini M., Potter J.D., Welch M.J., Wu A.H.B., and Kahn S.E. Standardisation of cardiac Troponin I assays: round robin of ten candidate reference materials. Clin Chem 47 (2001) 431-437
9. Wu A.H.B., Feng Y.-J., Moore R., Apple F.S., McPherson P.H., Buechler K.F., and Bodor G. Characterisation of cardiac Troponin subunit release after acute myocardial infarction and comparison of assays for Troponin T and I. Clin Chem 44 (1998) 1198-1208
10. Shi Q., Ling M., Zhang X., Kadijevic L., Liu S., and Laurino J.P. Degradation of cardiac Troponin I in serum complicates comparisons of cardiac Troponin I assays. Clin Chem 45 (1999) 1018-1025
11. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
12. Panteghini M., Pagani F., Yeo K.-T.J., Apple F.S., Christenson R.H., Dati F., Mair J., Ravkilde J., and Wu A.H.B. Evaluation of imprecision for cardiac Troponin assays at low-range concentrations. Clin Chem 50 (2004) 327-332
13. Davey R.X. Troponin reporting in Australia in 2003. Clin Biochem 42 (2005) 61-63
14. Koerbin G., Tate J.R., Potter J.M., and Hickman P.E. The comparative analytical performance of four Troponin I assays at low concentration. Clin Biochem 42 (2005) 19-23
15. Venge P., Lagerqvist B., Diderholm E., Lindahl B., and Wallentin L. Clinical performance of three cardiac Troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 89 (2002) 1035-1041
16. th percentile reference limits for cardiac Troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 49 (2003) 1331-1336
17. Williams E.J., Jones C.J.H., McDowell I.F.W., Tovey J.A., Thomas M.A., Wayte A.M.O., Brown N., Jenkins G.H., and Oleesky D.A. Recommended standards for biochemical markers of myocardial damage: All Wales clinical biochemistry audit group. Clin Biochem 42 (2005) 346-350